Gastroparesis Treatment Market Statistics for Upcoming Trends, Size, Share Value and Growth Opportunity by 2023 Including High Volume Industry Players

“Gastroparesis Treatment Market”
Market Research Future has released a new report on the Global Gastroparesis Treatment Market which reveals a notable CAGR of 3.8% during the forecast period of 2017 to 2023 with an estimated value of USD 5,323.62 Million by the end of 2023.

The Global Gastroparesis Treatment Market has been evaluated as a growing market. The global Gastroparesis Treatment market is expected to grow with CAGR of ~3.8% during the forecast period. Medtronic leads the market in the Gastric electric stimulation (GES) devices. Product development and increasing research and development in the device and implants segment is expected to yield the largest growth.

The other market driving factors of Gastroparesis are surgery on the stomach or vagus nerve, anorexia nervosa, use of narcotics that slow gastric contractions, gastro esophageal reflux disease, disorders, such as amyloidosis and scleroderma, Parkinson’s disease, metabolic disorders such as hypothyroidism etc.

The drugs product type segment is expected to account for the maximum market share of the global Gastroparesis treatment market. Prokinetic medications that stimulate gastric emptying, including metoclopramide, erythromycin, and domperidone, lead the drug segment. Although Idiopathic Gastroparesis leads the market share the Diabetic Gastroparesis is the fastest growing segment. Gastric electric stimulation (GES) etc. will however grow at a faster level as compared to drug segment.

Get Sample Report @

Global Gastroparesis Treatment Market – Key Players

Some of the key players in this market are:

  • Medtronic
  • Kimberly-Clark Corporation
  • Abbott Laboratories
  • Salix Pharmaceuticals Inc.
  • Boston Scientific Corporation
  • C. R. Bard Inc.
  • Janssen Global Services LLC
  • Cardinal Health Inc.
  • Alfa Wassermann SPA
  • Evoke Pharma
  • Rhythm Pharmaceuticals Inc.

Global Gastroparesis Treatment Market – Segmentation

Global Gastroparesis Treatment market has been segmented on the basis of Gastroparesis type which comprises idiopathic, diabetic, post-surgical and others. On the basis of drug class, the market comprises of prokinetic drugs, antiemetics, antidepressants and others. On the basis of other treatment; market is segmented into jejunostomy, gastric electric stimulation (GES) and parenteral nutrition.

Global Gastroparesis Treatment Market – Regional Analysis

Depending on geographic region, Gastroparesis Treatment market is segmented into four key regions: America, Europe, Asia Pacific, and Middle East & Africa. Globally, America is the largest market for Gastroparesis Treatment as there is a consistent technological advancement and good reimbursement scenario. Europe is the second-largest market for Gastroparesis Treatment. Asia Pacific region is expected to generate fastest growth due to larger population and unmet needs.  

Browse Complete 84 Pages Premium Research Report Enabled with Tables and Figures @ 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India